Mateos, M.V., P. Rodríguez-Otero, S.Z. Usmani, S. Kumar, J.C. Ye, S. Atrash, H. Magen, H. Quach, M.P. Chu, S. Trudel, J. Richter, H. Chuah, M. Gatt, E. Medvedova, S. Raza, D.H. Yoon, T. Ishida, J.V. Matous, L. Rosiñol, K. Onodera, C. Maffucci, E. Scott, C. Heuck, J. Zhang, T. Henninger, L. O’Rourke, P. Thakkar, M. Festa, L. Huang, J. Zhou, M. Takamoto, L. Pei, J. Lu, N. Au, M. Krevvata, and Y.C. Cohen. 2026. “P40 | EFFICACY AND SAFETY OF TALQUETAMAB + TECLISTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND EXTRAMEDULLARY DISEASE: UPDATED PHASE 2 RESULTS FROM THE RedirecTT-1 STUDY WITH EXTENDED FOLLOW-UP”. Haematologica 111 (s2). Pavia, Italy. https://doi.org/10.3324/haematol.2026.s2.14055.